Serzone and Bronchospasm aggravated - a phase IV clinical study of FDA data

Summary:

Bronchospasm aggravated is reported as a side effect among people who take Serzone (nefazodone hydrochloride), especially for people who are male, 60+ old, also take Xanax, and have Emphysema.

The phase IV clinical study analyzes which people have Bronchospasm aggravated when taking Serzone. It is created by eHealthMe based on reports of 7,594 people who have side effects when taking Serzone from the FDA, and is updated regularly.

What is Serzone?

Serzone has active ingredients of nefazodone hydrochloride. It is often used in depression. eHealthMe is studying from 7,695 Serzone users. Check the latest studies of Serzone.

What is Bronchospasm aggravated?

Bronchospasm aggravated (spasm of bronchial smooth muscle producing narrowing of the bronchi) is found to be associated with 1,003 drugs and 328 conditions by eHealthMe. Check the latest studies of Bronchospasm aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

7,594 people reported to have side effects when taking Serzone.
Among them, 17 people (0.22%) have Bronchospasm aggravated.

Could Serzone cause Bronchospasm aggravated?

Among these 17 people:

What is the gender of people who have Bronchospasm aggravated when taking Serzone? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Bronchospasm aggravated when taking Serzone? *

What are other drugs people take besides Serzone? *

What are other side effects people have besides Bronchospasm aggravated? *

Loss Of Consciousness: 10 people, 58.82%
Chronic Obstructive Airways Disease Exacerbated: 10 people, 58.82%
Weakness: 9 people, 52.94%
Drug Ineffective: 9 people, 52.94%
Circulatory Collapse: 8 people, 47.06%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 8 people, 47.06%
Chest Pain: 7 people, 41.18%
Paleness (unusual lightness of skin colour): 7 people, 41.18%
Peripheral Coldness: 6 people, 35.29%
Oedema Lower Limb (fluid collection in tissue of lower leg): 5 people, 29.41%

What are the existing conditions these people have? *

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 7 people, 41.18%

* Approximation only. Some reports may have incomplete information.

Do you take Serzone and have Bronchospasm aggravated?

- Check whether Bronchospasm aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serzone:

Serzone (7,695 reports)

Browse all side effects of Serzone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchospasm aggravated:

Bronchospasm aggravated (1,003 drugs)

Browse all the conditions that are associated with Bronchospasm aggravated:

Bronchospasm aggravated (328 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nefazodone hydrochloride (the active ingredients of Serzone) and Serzone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.